Literature DB >> 21271243

Autoimmune-mediated encephalitis.

Philippe Demaerel1, Wim Van Dessel, Wim Van Paesschen, Rik Vandenberghe, Koen Van Laere, Jennifer Linn.   

Abstract

Autoimmune-mediated encephalitis may occur as a paraneoplastic or as a non-paraneoplastic condition. The role of neuroimaging in autoimmune-mediated encephalitis has changed in the last decade partly due to improvements in sequence optimisation and higher field strength and partly due to the discovery of an increasing number of antibodies to neuronal cell and cell membrane antigens. Imaging is important since it can support the clinical diagnosis particularly in the absence of antibodies. Structural imaging findings can be subtle and are usually best seen on FLAIR images. A progressive as well as a relapsing-remitting course can be observed. Autoimmune-mediated encephalitis is classically linked to involvement of the hippocampus and amygdala, but extensive changes in the temporal cortex, basal ganglia, hypothalamus, brain stem, frontal and parietal cortex are not unusual. This report is based on a review of the literature (except the literature in Japanese) and own findings in patients with autoimmune-mediated encephalitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271243     DOI: 10.1007/s00234-010-0832-0

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  42 in total

1.  Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.

Authors:  P Sillevis Smitt; A Kinoshita; B De Leeuw; W Moll; M Coesmans; D Jaarsma; S Henzen-Logmans; C Vecht; C De Zeeuw; N Sekiyama; S Nakanishi; R Shigemoto
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

2.  Limbic encephalitis: comparison of FDG PET and MR imaging findings.

Authors:  J M Provenzale; D P Barboriak; R E Coleman
Journal:  AJR Am J Roentgenol       Date:  1998-06       Impact factor: 3.959

3.  "Limbic encephalitis" and its association with carcinoma.

Authors:  J A Corsellis; G J Goldberg; A R Norton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

Review 4.  Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis.

Authors:  Rainer Scheid; Thomas Lincke; Raymond Voltz; D Yves von Cramon; Osama Sabri
Journal:  Arch Neurol       Date:  2004-11

5.  Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy.

Authors:  C G Bien; H Urbach; J Schramm; B M Soeder; A J Becker; R Voltz; A Vincent; C E Elger
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

6.  Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images.

Authors:  Andrew McKeon; J Eric Ahlskog; Jeffrey W Britton; Jeffrey A Britton; Vanda A Lennon; Sean J Pittock
Journal:  Arch Neurol       Date:  2009-02

Review 7.  Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates.

Authors:  Sandip Basu; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

8.  GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma.

Authors:  John C McHugh; Brian Murray; Radhakrishnan Renganathan; Sean Connolly; Tim Lynch
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

Review 9.  Limbic encephalitis - a review.

Authors:  N E Anderson; P A Barber
Journal:  J Clin Neurosci       Date:  2008-04-14       Impact factor: 1.961

10.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.

Authors:  S Younes-Mhenni; M F Janier; L Cinotti; J C Antoine; F Tronc; V Cottin; P J Ternamian; P Trouillas; J Honnorat
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

View more
  8 in total

1.  Metabolic-structural concordance in paraneoplastic limbic encephalitis.

Authors:  K E Goffin; D Ooms; R Ahmad; P Demaerel; W Van Paesschen; K Van Laere; J Vansteenkiste; C M Deroose; O Gheysens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-08       Impact factor: 9.236

Review 2.  Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis.

Authors:  B P Kelley; S C Patel; H L Marin; J J Corrigan; P D Mitsias; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

Review 3.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

Review 4.  Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders.

Authors:  A J da Rocha; R H Nunes; A C M Maia; L L F do Amaral
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-17       Impact factor: 3.825

5.  Limbic Tumors of the Temporal Lobe: Radiologic-Pathologic Correlation.

Authors:  A A Capizzano; P Kirby; T Moritani
Journal:  Clin Neuroradiol       Date:  2014-01-29       Impact factor: 3.649

Review 6.  "Unforgettable" - a pictorial essay on anatomy and pathology of the hippocampus.

Authors:  Sven Dekeyzer; Isabelle De Kock; Omid Nikoubashman; Stephanie Vanden Bossche; Ruth Van Eetvelde; Jeroen De Groote; Marjan Acou; Martin Wiesmann; Karel Deblaere; Eric Achten
Journal:  Insights Imaging       Date:  2017-01-20

7.  Seronegative Autoimmune Basal Ganglia Encephalitis Presenting as Acute Parkinsonism and Refractory Faciobrachial Seizures: A Case Report.

Authors:  Anamika Giri; Amol Andhale; Sourya Acharya; Rohan Kumar Singh; Dhruv Talwar
Journal:  Cureus       Date:  2022-01-17

Review 8.  Are onconeural antibodies a clinical phenomenology in paraneoplastic limbic encephalitis?

Authors:  Hongliang Zhang; Chunkui Zhou; Limin Wu; Fengming Ni; Jie Zhu; Tao Jin
Journal:  Mediators Inflamm       Date:  2013-07-25       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.